Journal of Innovative Optical Health Sciences, Volume. 6, Issue 2, 1350011(2013)
CHOP THERAPY INDUCED MITOCHONDRIAL REDOX STATE ALTERATION IN NON-HODGKIN'S LYMPHOMA XENOGRAFTS
[1] [1] L. Z. Li, H. N. Xu, M. Ranji, S. Nioka, B. Chance, "Mitochondrial redox imaging for cancer diagnostic and therapeutic studies," JIOHS 2, 325-341 (2009).
[2] [2] B. Quistorff, J. C. Haselgrove, B. Chance, "High spatial resolution readout of 3-D metabolic organ structure: An automated, low-temperature redox ratio-scanning instrument," Anal. Biochem. 148, 389-400 (1985).
[3] [3] H. N. Xu, S. Nioka, J. D. Glickson, B. Chance, L. Z. Li, "Quantitative mitochondrial redox imaging of breast cancer metastatic potential," J. Biomed. Opt. 15, 036010 (2010).
[4] [4] L. Z. Li, R. Zhou, H. N. Xu, L. Moon, T. Zhong, E. J. Kim, H. Qiao, R. Reddy, D. Leeper, B. Chance, J. D. Glickson, "Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential," Proc. Natl. Acad. Sci. USA 106, 6608-6613 (2009).
[5] [5] H. N. Xu, S. Nioka, B. Chance, L. Z. Li, "Heterogeneity of mitochondrial redox state in premalignant pancreas in a PTEN null transgenic mouse model," Adv. Exp. Med. Biol. 701, 207-213, (2011).
[6] [6] Z. Zhang, D. Blessington, H. Li, T. M. Busch, J. Glickson, Q. Luo, B. Chance, G. Zheng, "Redox ratio of mitochondria as an indicator for the response of photodynamic therapy," J. Biomed. Opt. 9, 772-778 (2004).
[7] [7] H. Poptani, N. Bansal, W. T. Jenkins, D. Blessington, A. Mancuso, D. S. Nelson, M. Feldman, E. J. Delikatny, B. Chance, J. D. Glickson, "Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: C-13 magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning," Cancer Res. 63, 8813-8820 (2003).
[8] [8] A. C. Society, Cancer Facts & Figures 2012, American Cancer Society, Atlanta (2012).
[9] [9] R. I. Fisher, E. R. Gaynor, S. Dahlberg, M. M. Oken, T. M. Grogan, E. M. Mize, J. H. Glick, C. A. Coltman, T. P. Miller, "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma," N. Engl. J. Med. 328, 1002-1006 (1993).
[10] [10] R. M. Mohammad, A. Al-Katib, A. Aboukameel, D. R. Doerge, F. Sarkar, O. Kucuk, "Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy," Mol. Cancer Therap. 2, 1361-1368 (2003).
[11] [11] S.-C. Lee, M. Q. Huang, D. S. Nelson, S. Pickup, S. Wehrli, O. Adegbola, H. Poptani, E. J. Delikatny, J. D. Glickson, "In vivo MRS markers of response to CHOP chemotherapy in the WSU-DLCL2 human diffuse large B-cell lymphoma xenograft," NMR Biomed. 21, 723 (2008).
[12] [12] H. N. Xu, B. Wu, S. Nioka, B. Chance, L. Z. Li, "Quantitative redox scanning of tissue samples using a calibration procedure," JIOHS 2, 375-385 (2009).
[13] [13] S. Fulda, L. Galluzzi, G. Kroemer, "Targeting mitochondria for cancer therapy," Nat. Rev. Drug Discov. 9, 447-464 (2010).
[14] [14] G. G. D'Souza, M. A. Wagle, V. Saxena, A. Shah, "Approaches for targeting mitochondria in cancer therapy," Biochim. Biophys. Acta 1807, 689-696 (2011).
[15] [15] N. Andre, D. Braguer, G. Brasseur, A. Goncalves, D. Lemesle-Meunier, S. Guise, M. A. Jordan, C. Briand, "Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells," Cancer Res. 60, 5349-5353 (2000).
[16] [16] A. V. Kuznetsov, R. Margreiter, A. Amberger, V. Saks, M. Grimm, "Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicininduced cell death," Biochim. Biophys. Acta. 1813, 1144-1152 (2011).
[17] [17] S. Lobert, B. Vulevic, J. J. Correia, "Interaction of vinca alkaloids with tubulin: A comparison of vinblastine, vincristine, and vinorelbine," Biochemistry 35, 6806-6814 (1996).
[18] [18] R. J. Owellen, C. A. Hartke, R. M. Dickerson, F. O. Hains, "Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class," Cancer Res. 36, 1499-1502 (1976).
[19] [19] R. J. Owellen, A. H. Owens, Jr., D. W. Donigian, "The binding of vincristine, vinblastine and colchicine to tubulin," Biochem. Biophys. Res. Commun. 47, 685-691 (1972).
[20] [20] M. Carre, N. Andre, G. Carles, H. Borghi, L. Brichese, C. Briand, D. Braguer, "Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel," J. Biol. Chem. 277, 33664-33669 (2002).
[21] [21] M. Ranji, D. L. Jaggard, B. Chance, "Observation of mitochondrial morphology and biochemistry changes undergoing apoptosis by angularly resolved light scattering and cryoimaging," Proc. SPIE 6087, 60870K (2006).
[22] [22] L. Z. Li, "Imaging mitochondrial redox potential and its possible link to tumor metastatic potential," J. Bioenerg. Biomembr. 44, 645-653 (2012).
[23] [23] B. Chance, H. Baltscheffsky, "Respiratory enzymes in oxidative phosphorylation. VII. Binding of intramitochondrial reduced pyridine nucleotide," J. Biol. Chem. 233, 736-739 (1958).
[24] [24] B. Chance, G. R. Williams, "A method for the localization of sites for oxidative phosphorylation," Nature 176, 250-254 (1955).
[25] [25] I. J. Fidler, "Review: Biologic heterogeneity of cancer metastases," Breast Cancer Res. Treat. 9, 17-26 (1987).
[26] [26] I. J. Fidler, I. R. Hart, "Biological diversity in metastatic neoplasms: Origins and implications," Science 217, 998-1003 (1982).
[27] [27] G. H. Heppner, "Tumor heterogeneity," Cancer Res. 44, 2259-2265 (1984).
[28] [28] G. H. Heppner, F. R. Miller, "The cellular basis of tumor progression," Int. Rev. Cytol. 177, 1-56 (1998).
[29] [29] M. Gerlinger, A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N. Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C. R. Santos, M. Nohadani, A. C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P. A. Futreal, C. Swanton, "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing," N. Engl. J. Med. 366, 883-92 (2012).
[30] [30] H. N. Xu, T. A. Mir, S. C. Lee, M. Feng, N. Farhad, R. Choe, J. D. Glickson, L. Z. Li, "Mapping the Redox State of CHOP-treated Non-Hodgkin's Lymphoma Xenografts in Mice," Adv. Exp. Med. Biol. (in press.)
Get Citation
Copy Citation Text
H. N. XU, H. ZHAO, T. A. MIR, S. C. LEE, M. FENG, R. CHOE, J. D. GLICKSON, L. Z. LI. CHOP THERAPY INDUCED MITOCHONDRIAL REDOX STATE ALTERATION IN NON-HODGKIN'S LYMPHOMA XENOGRAFTS[J]. Journal of Innovative Optical Health Sciences, 2013, 6(2): 1350011
Received: Dec. 25, 2012
Accepted: Jan. 4, 2013
Published Online: Jan. 10, 2019
The Author Email: LI L. Z. (linli@mail.med.upenn.edu)